Potential Rett Drug Binding to Its Target (IMAGE)
Caption
X-ray crystallography shows at the atomic level how Tonks' experimental drug for Rett syndrome, called CPT157633, binds to its target, the enzyme PTP1B, which helps regulate a key metabolic signaling cascade.
Credit
Tonks Lab, CSHL
Usage Restrictions
please give credit
License
Licensed content